BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 11419840)

  • 1. Physical activity, biliary lipids, and gallstones in obese subjects.
    Chuang CZ; Martin LF; LeGardeur BY; Lopez A
    Am J Gastroenterol; 2001 Jun; 96(6):1860-5. PubMed ID: 11419840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma.
    Henriksson P; Einarsson K; Eriksson A; Kelter U; Angelin B
    J Clin Invest; 1989 Sep; 84(3):811-6. PubMed ID: 2760214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.
    Shaffer EA; Small DM
    J Clin Invest; 1977 May; 59(5):828-40. PubMed ID: 856870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conceptual evolution regarding the pathogenesis of biliary lithiasis due to cholesterol calculi].
    Rigotti A; Miquel JF; Nervi F
    Rev Med Chil; 1991 Mar; 119(3):312-20. PubMed ID: 1842127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of hypolipidemic treatment on the composition of bile and the risk or cholesterol gallstone disease].
    Zák A; Zeman M; Hrubant K; Vecka M; Tvrzická E
    Cas Lek Cesk; 2007; 146(1):24-34. PubMed ID: 17310581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipid lipoproteins and biliary lipid composition in female gallstone patients.
    Alvaro D; Angelico F; Attili AF; Antonini R; Mazzarella B; Ginanni Corradini S; Gentile S; Bracci F; Angelico M
    Biomed Biochim Acta; 1986; 45(6):761-8. PubMed ID: 3753480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between hepatic and biliary lipid metabolism and secretion in genetically gallstone-susceptible and gallstone-resistant mice.
    Xu G; Zhao L; Fuchs M
    Chin Med J (Engl); 2002 Sep; 115(9):1292-5. PubMed ID: 12411097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary lipid secretion, bile acid metabolism, and gallstone formation are not impaired in hepatic lipase-deficient mice.
    Amigo L; Mardones P; Ferrada C; Zanlungo S; Nervi F; Miquel JF; Rigotti A
    Hepatology; 2003 Sep; 38(3):726-34. PubMed ID: 12939599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin-resistant obese mice have paradoxically low biliary cholesterol saturation.
    Tran KQ; Graewin SJ; Swartz-Basile DA; Nakeeb A; Svatek CL; Pitt HA
    Surgery; 2003 Aug; 134(2):372-7. PubMed ID: 12947343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery.
    Gustafsson U; Benthin L; Granström L; Groen AK; Sahlin S; Einarsson C
    Hepatology; 2005 Jun; 41(6):1322-8. PubMed ID: 15834935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical-chemical basis of gallstone formation.
    Donovan JM; Carey MC
    Gastroenterol Clin North Am; 1991 Mar; 20(1):47-66. PubMed ID: 2022425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit.
    Shoda J; He BF; Tanaka N; Matsuzaki Y; Osuga T; Yamamori S; Miyazaki H; Sjövall J
    Hepatology; 1995 May; 21(5):1291-302. PubMed ID: 7737634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of gallstones.
    Weisberg HF
    Ann Clin Lab Sci; 1984; 14(4):243-51. PubMed ID: 6380394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical epidemiology of gallbladder cancer.
    Strom BL; Soloway RD; Rios-Dalenz J; Rodriguez-Martinez HA; West SL; Kinman JL; Crowther RS; Taylor D; Polansky M; Berlin JA
    Hepatology; 1996 Jun; 23(6):1402-11. PubMed ID: 8675157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of apolipoprotein E polymorphism on bile lipid composition and the formation of cholesterol gallstone.
    Hasegawa K; Terada S; Kubota K; Itakura H; Imamura H; Ohnishi S; Aoki T; Ijichi M; Saiura A; Makuuchi M
    Am J Gastroenterol; 2003 Jul; 98(7):1605-9. PubMed ID: 12873586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human gallbladder mucosal function: effects on intraluminal fluid and lipid composition in health and disease.
    Ginanni Corradini S; Yamashita G; Nuutinen H; Chernosky A; Williams C; Hays L; Shiffman ML; Walsh RM; Svanvik J; Della Guardia P; Capocaccia L; Holzbach RT
    Dig Dis Sci; 1998 Feb; 43(2):335-43. PubMed ID: 9512127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathobiology of cholesterol gallstone disease: from equilibrium ternary phase diagram to agents preventing cholesterol crystallization and stone formation.
    Portincasa P; Moschetta A; Calamita G; Margari A; Palasciano G
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Mar; 3(1):67-81. PubMed ID: 12570727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acid metabolism in cirrhosis. 3. Biliary lipid secretion in patients with cirrhosis and its relevance to gallstone formation.
    Vlahcevic ZR; Yoshida T; Juttijudata P; Bell CC; Swell L
    Gastroenterology; 1973 Feb; 64(2):298-303. PubMed ID: 4686338
    [No Abstract]   [Full Text] [Related]  

  • 19. Contribution of biliary lipids to calcium binding in bile.
    Williamson BW; Percy-Robb IW
    Gastroenterology; 1980 Apr; 78(4):696-702. PubMed ID: 7353756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased activity in the biliary Con A-binding fraction accounts for the difference in crystallization behavior in bile from Chilean gallstone patients compared with Dutch gallstone patients.
    Miquel JF; Van Der Putten J; Pimentel F; Mok KS; Groen AK
    Hepatology; 2001 Feb; 33(2):328-32. PubMed ID: 11172333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.